Barclays Lowers Omada Health (NASDAQ:OMDA) Price Target to $17.00

Omada Health (NASDAQ:OMDA) had its target price dropped by Barclays from $22.00 to $17.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 25.74% from the company’s previous close.

OMDA has been the topic of a number of other reports. The Goldman Sachs Group reaffirmed a “buy” rating and set a $26.00 price target on shares of Omada Health in a research report on Friday, January 16th. Weiss Ratings restated a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price target on shares of Omada Health in a report on Thursday, January 22nd. Morgan Stanley set a $32.00 price objective on Omada Health in a research note on Thursday, December 18th. Finally, Evercore upped their target price on Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Eight analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Omada Health presently has an average rating of “Moderate Buy” and a consensus target price of $24.60.

Omada Health Stock Up 4.0%

OMDA stock opened at $13.52 on Tuesday. The company has a market cap of $782.94 million and a price-to-earnings ratio of -54.08. The business has a fifty day simple moving average of $14.11 and a 200-day simple moving average of $18.77. Omada Health has a 52 week low of $10.28 and a 52 week high of $28.40.

Insider Transactions at Omada Health

In other news, President Wei-Li Shao sold 5,618 shares of the firm’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $16.13, for a total transaction of $90,618.34. Following the completion of the sale, the president directly owned 69,079 shares in the company, valued at $1,114,244.27. This trade represents a 7.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sean P. Duffy sold 230,479 shares of Omada Health stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $15.60, for a total value of $3,595,472.40. Following the sale, the chief executive officer directly owned 126,644 shares in the company, valued at approximately $1,975,646.40. The trade was a 64.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 276,893 shares of company stock valued at $4,336,787.

Hedge Funds Weigh In On Omada Health

Several institutional investors and hedge funds have recently made changes to their positions in OMDA. Quarry LP bought a new stake in shares of Omada Health in the fourth quarter worth $29,000. TD Waterhouse Canada Inc. bought a new stake in shares of Omada Health in the 4th quarter worth about $32,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the 2nd quarter valued at about $32,000. Strs Ohio bought a new position in shares of Omada Health during the third quarter worth about $38,000. Finally, Inlight Wealth Management LLC acquired a new position in Omada Health in the fourth quarter worth about $45,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.